
Roger Paredes
Roger Paredes obtained a degree and doctorate in Medicine and Surgery from the Autonomous University of Barcelona (UAB). His specialism in HIV resistance, at Brigham & Women's Hospital in Boston and Harvard Medical School, was funded by a post-doctoral scholarship from “la Caixa”. He has demonstrated the clinical utility of new methods of sequencing HIV in both high- and low-income countries. He is a member of the WHO HIV Drug Resistance Strategy (ResNet) Steering Committee and of the International Antiviral Society-USA, which publishes an international annual update of drug resistance mutations in HIV-1. He is co-author of the Rega algorithm for interpreting resistance to antiretrovirals and is a virologist for the EuroSIDA European cohort. His group has led pioneering research into the role of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation. He combines his research with a medical care role in the HIV unit of the Germans Trias i Pujol University Hospital (Badalona) and a training role as a associate professor in the Chair of Infectious Diseases and Immunity at the University of Vic-University of Central Catalonia (UVic-UCC).
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.